Pages that link to "Q77404557"
Jump to navigation
Jump to search
The following pages link to Changes in arterial structure and function under trandolapril-verapamil combination in hypertension (Q77404557):
Displaying 27 items.
- Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension (Q24240561) (← links)
- Antihypertensive and renoprotective effects of trandolapril/verapamil combination: a meta-analysis of randomized controlled trials (Q33599683) (← links)
- Effects of verapamil slow release plus trandolapril combination therapy on essential hypertension (Q33738993) (← links)
- Arterial stiffness and cardiovascular therapy (Q34079790) (← links)
- Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension (Q34991490) (← links)
- Effect of angiotensin II blockade on central blood pressure and arterial stiffness in subjects with hypertension (Q35026729) (← links)
- A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension (Q35179552) (← links)
- The genetic basis for altered blood vessel function in disease: large artery stiffening (Q36012883) (← links)
- Trandolapril/verapamil sustained release: a review of its use in the treatment of essential hypertension (Q36237553) (← links)
- Managing hypertension in diabetic patients--focus on trandolapril/verapamil combination (Q36536275) (← links)
- Arterial stiffness and pharmacological interventions--the TRanscend arterial stiffNess Substudy (TRANS study). (Q36536294) (← links)
- Preventing left ventricular hypertrophy by ACE inhibition in hypertensive patients with type 2 diabetes: a prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT). (Q36807421) (← links)
- Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy (Q36909397) (← links)
- Role of increased aortic stiffness in the pathogenesis of heart failure (Q36947412) (← links)
- Sex difference in cardiovascular risk: role of pulse pressure amplification (Q37026861) (← links)
- The pathogenesis of arterial stiffness and its prognostic value in essential hypertension and cardiovascular diseases (Q37195725) (← links)
- Aging and Arterial Stiffness (Q37801786) (← links)
- Arterial stiffness: from physiology to clinical implications. (Q37879653) (← links)
- Vascular compliance in blood pressure (Q37898985) (← links)
- Mechanical properties of normal and diseased cerebrovascular system. (Q38003989) (← links)
- Effect of antihypertensive therapy on cognitive functions of patients with hypertension (Q41893689) (← links)
- Effects of atorvastatin on aortic pulse wave velocity in patients with hypertension and hypercholesterolaemia: a preliminary study (Q44208113) (← links)
- Relationships between brachial-ankle pulse wave velocity and conventional atherosclerotic risk factors in community-dwelling people (Q45147751) (← links)
- Selective reduction of central pulse pressure under angiotensin blockage in SHR: role of the fibronectin-alpha5beta1 integrin complex. (Q46020976) (← links)
- Cardiovascular prevention: relationships between arterial aging and chronic drug treatment (Q60593873) (← links)
- Association between pulse pressure, carotid intima-media thickness and carotid and/or iliofemoral plaque in hypertensive patients (Q75355912) (← links)
- Differences in central systolic blood pressure and aortic stiffness between aerobically trained and sedentary individuals (Q83636973) (← links)